01177.HK
Sino Biopharmaceutical Limited
HKSE · Healthcare · Biotechnology · HK
HKD 4.85
−0.10%Margins
Gross margin
82.4%
EBITDA margin
31.7%
EBIT margin
29.8%
Net margin
7.1%
FCF margin
15.3%
7.3%
Return on equity
2.9%
Return on assets
20.2%
Return on invested capital
0.41x
Asset turnover
HKD 7.2B
Cash from operations
HKD 1.80
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026